429 MMSE の下位項目は経験記憶の妥当性のあるテストとして使えるか? 自由想起とヒントによる想起の比較
N Kandiah , K Narasimhalu , J Lee , CLPH Chen
Dement Geriatr Cogn Disord 27 399 -403
2009
Control of Ca2+ oscillations in astrocytes in situ
A Heidemann , C Schipke , O Peters , H Kettenmann
GLIA 55 -55
2003
Clinical efficacy and cognitive side effects of bifrontal versus right unilateral electroconvulsive therapy (ECT): a short-term randomised controlled trial in pharmaco-resistant major depression.
Gerhard W. Eschweiler , Reinhard Vonthein , Ruediger Bode , Michael Huell
Journal of Affective Disorders 101 ( 1) 149 -157
54
2007
Basal forebrain atrophy along the Alzheimer’s disease spectrum and its relevance for subjective cognitive decline
Shumei Li , Michel J. Grothe , Marcel Daamen , Steffen Wolfsgruber
1
2020
A residual marker of cognitive reserve is associated with resting-state intrinsic functional connectivity along the Alzheimer’s disease continuum
E Ersoezlue , R Perneczky , M Tatò , J Utecht
Journal of Alzheimer's Disease 92 ( 3) 925 -940
2
2023
Arterial hypertension and β-amyloid accumulation have spatially overlapping effects on posterior white matter hyperintensity volume: a cross-sectional study
J Bernal , S Schreiber , I Menze , A Ostendorf
Alzheimer's research & therapy 15 ( 1) 97 -97
5
2023
A generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings
H Baumeister , JW Vogel , PS Insel , L Kleineidam
Brain awae118 -awae118
1
2024
Machine learning‐based classification of Alzheimer's disease and its at‐risk states using personality traits, anxiety, and depression
KF Waschkies , J Soch , M Darna , A Richter
International journal of geriatric psychiatry 38 ( 10) e6007 -e6007
1
2023
The comorbidity and co-medication profile of patients with progressive supranuclear palsy
Stephan Greten , Florian Wegner , Ida Jensen , Lea Krey
Journal of neurology 271 ( 2) 782 -793
1
2024
Plasma extracellular vesicle Tau isoform ratios and TDP-43 inform about molecular pathology in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis
Madhurima Chatterjee , Selcuk Özdemir , Christian Fritz , Wiebke Möbius
2023
Diminished utility of fMRI subsequent memory models with increasing severity across the Alzheimer's disease risk spectrum
Joram Soch , Anni Richter , Jasmin M Kizilirmak , Hartmut Schütze
medRxiv 2023.09. 11.23295362 -2023.09. 11.23295362
2
2023
Reduced expression of fMRI subsequent memory effects with increasing severity across the Alzheimer’s disease risk spectrum
Joram Soch , Anni Richter , Jasmin M Kizilirmak , Hartmut Schütze
medRxiv 2023.09. 11.23295362 -2023.09. 11.23295362
2023
Influence of chronic Alzheimer-disease-like pathology on astrocytes
Oliver Peters , Carola G Schipke , Andreas Phillips , Brigitte Haas
BIOLOGICAL PSYCHIATRY 61 ( 8) 120S -121S
2007
Dementia Competence Network
Coordinating Center , Oliver Peters , Ulrike Jansen , Presse-und Öffentlichkeitsarbeit
Projects Research 7 -7
A polymorphic microsatellite repeat within the ECE-1c promoter is involved in transcriptional start site determination, human evolution, and Alzheimer's disease.
Y. Li , K. Seidel , P. Marschall , M. Klein
The Journal of Neuroscience 32 ( 47) 16807 -16820
15
2012
Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease
M. Daerr , S. Wolfsgruber , F. Jessen , J. Popp
Neurology 78 ( 6) 379 -386
127
2012
A novel MRI-biomarker candidate for Alzheimer's disease composed of regional brain volume and perfusion variables.
C. Luckhaus , M. Jänner , M. Cohnen , M. O. Flüß
European Journal of Neurology 17 ( 12) 1437 -1444
13
2010
Comparison of immunosorbent assays for the quantification of biomarkers for Alzheimer's disease in human cerebrospinal fluid.
C.G. Schipke , S. Prokop , F.L. Heppner , I. Heuser
Dementia and Geriatric Cognitive Disorders 31 ( 2) 139 -145
17
2011
P06 Concordance of florbetapir (18F) PET and Elecsys® β-Amyloid(1–42) CSF immunoassay in the CREAD (BN29552) study of crenezumab in prodromal-to-mild AD
T. Grimmer , C. Rabe , M. Navarro , D. Clayton
Clinical Neurophysiology 130 ( 8)
2019